Sartorius AG (SRT)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Sartorius AG (SRT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011034
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sartorius AG (Sartorius) manufactures and distributes laboratory and process technology equipment. The company’s lab products portfolio includes laboratory instruments, such as pipettes, laboratory water purification systems, weight sets and lab balances. It provides bioprocess solutions for efficient biologic manufacture of medications and vaccines. Sartorius also offers wide range of products for purification, separation and concentration, and solutions for storage and transportation of intermediate and final biological products. The company serves pharmaceutical, biotechnology, chemical, food and beverage industries, and numerous research and educational institutes and laboratories in Germany and across the world. It has manufacturing facilities in Europe, Asia and America. Sartorius is headquartered in Goettingen, Niedersachsen, Germany.

Sartorius AG (SRT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Sartorius AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Sartorius AG, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Sartorius AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Sartorius AG, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Sartorius AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Sartorius AG, Medical Equipment, Deal Details 11
Venture Financing 11
IntelliCyt Raises USD5.4 Million in Venture Financing Round 11
IntelliCyt Raises USD0.05 Million in Venture Financing 12
IntelliCyt Raises US$8.4 Million In Series B Financing 13
ViroCyt Raises Funds In Second Round Of Growth Financing 14
Partnerships 15
Sartorius Stedim Biotech Enters into Agreement with Nova Biomedical 15
Notable Labs Enters into Agreement with IntelliCyt 16
Genedata Enters into Integration Agreement with IntelliCyt 17
Sartorius Stedim Biotech Enters Into An Agreement With Bosch Packaging 18
Sartorius Stedim Biotech Enters Into Co-Development With Refine Technology 19
Sartorius Stedim Enters Into An Agreement With RAUMEDIC 20
Acquisition 21
Sartorius Acquires Essen BioScience for USD320 Million 21
Sartorius Stedim Biotech Acquires kSep for USD32.6 Million 22
Sartorius Acquires ViroCyt for USD18.5 Million 23
Sartorius Acquires IntelliCyt for USD103.8 Million 24
Sartorius AG – Key Competitors 25
Sartorius AG – Key Employees 26
Sartorius AG – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 30
Strategy And Business Planning 30
Jul 18, 2016: Sartorius Expands Production Site in England 30
Financial Announcements 31
Jul 21, 2017: Business Figures for the First Half of 2017: Sartorius Continues to Grow 31
Jul 21, 2017: Solid growth at Sartorius Stedim Biotech; profits continue to rise 33
Apr 24, 2017: First-quarter figures: Sartorius starts off 2017 with double-digit growth 34
Feb 23, 2017: Sartorius Reviews Fiscal 2016 35
Jan 30, 2017: Sartorius Grows by Double Digits in Sales Revenue and Earnings in 2016 – Positive Outlook for 2017 37
Oct 24, 2016: Nine-month Figures for 2016: Sartorius Continues to Grow by Strong Double Digits 39
Jul 25, 2016: Business Figures for the First Half of 2016: Sartorius Continues to Grow by Strong Double Digits 40
Apr 20, 2016: Q1 Results: Sartorius Off to a Dynamic Start in 2016 42
Feb 26, 2016: Sartorius Reviews Fiscal 2015 Results 43
Feb 01, 2016: Sartorius Grows by Double Digits in Sales and Profit in 2015 – Positive Outlook for 2016 – Targets for 2020 Updated 45
Corporate Communications 46
Mar 09, 2017: Sartorius appoints Gerry MacKay as Executive Vice President of Marketing, Sales and Services for its Laboratory Division 46
Feb 21, 2017: Resolutions of the Sartorius Supervisory Board 47
Other Significant Developments 48
Oct 16, 2017: Sartorius Group: Key Figures on 9-Month Business Development in 2017 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49

List of Tables
Sartorius AG, Medical Equipment, Key Facts, 2016 2
Sartorius AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Sartorius AG, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Sartorius AG, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Sartorius AG, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Sartorius AG, Deals By Market, 2011 to YTD 2017 9
Sartorius AG, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
IntelliCyt Raises USD5.4 Million in Venture Financing Round 11
IntelliCyt Raises USD0.05 Million in Venture Financing 12
IntelliCyt Raises US$8.4 Million In Series B Financing 13
ViroCyt Raises Funds In Second Round Of Growth Financing 14
Sartorius Stedim Biotech Enters into Agreement with Nova Biomedical 15
Notable Labs Enters into Agreement with IntelliCyt 16
Genedata Enters into Integration Agreement with IntelliCyt 17
Sartorius Stedim Biotech Enters Into An Agreement With Bosch Packaging 18
Sartorius Stedim Biotech Enters Into Co-Development With Refine Technology 19
Sartorius Stedim Enters Into An Agreement With RAUMEDIC 20
Sartorius Acquires Essen BioScience for USD320 Million 21
Sartorius Stedim Biotech Acquires kSep for USD32.6 Million 22
Sartorius Acquires ViroCyt for USD18.5 Million 23
Sartorius Acquires IntelliCyt for USD103.8 Million 24
Sartorius AG, Key Competitors 25
Sartorius AG, Key Employees 26
Sartorius AG, Other Locations 27
Sartorius AG, Subsidiaries 27

★海外企業調査レポート[Sartorius AG (SRT)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Globo Comunicacao e Participacoes S.A.:企業の戦略的SWOT分析
    Globo Comunicacao e Participacoes S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Media General, Inc.:企業のM&A・事業提携・投資動向
    Media General, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Media General, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Bakkavor Group Limited:企業の戦略・SWOT・財務情報
    Bakkavor Group Limited - Strategy, SWOT and Corporate Finance Report Summary Bakkavor Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Akcansa Cimento Sanayi ve Ticaret AS:企業の戦略・SWOT・財務情報
    Akcansa Cimento Sanayi ve Ticaret AS - Strategy, SWOT and Corporate Finance Report Summary Akcansa Cimento Sanayi ve Ticaret AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • China Resources Enterprise Ltd:企業の戦略的SWOT分析
    China Resources Enterprise Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Groupe Sodiaal:企業の戦略・SWOT・財務情報
    Groupe Sodiaal - Strategy, SWOT and Corporate Finance Report Summary Groupe Sodiaal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Gunvor Group Limited-石油・ガス分野:企業M&A・提携分析
    Summary Gunvor Group Limited (Gunvor) is a vertically integrated energy trading company. It is one of the global traders of physical crude oil; refined products and energy; and metals and bulk materials. The company provides integrated trading products and logistics service to connect suppliers upst …
  • Medicago Inc-製薬・医療分野:企業M&A・提携分析
    Summary Medicago Inc (Medicago), a subsidiary of Mitsubishi Tanabe Pharma Corp is a biopharmaceutical company that develops and produces vaccines and antibodies. The company concentrates on the discovery and development of novel vaccines and therapeutic proteins for infectious diseases. Its pipeline …
  • Selecta Biosciences Inc (SELB):製薬・医療:M&Aディール及び事業提携情報
    Summary Selecta Biosciences Inc (Selecta Biosciences) is a biopharmaceutical company that develops immunotherapies and vaccines for the treatment and prevention of human diseases. The company’s pipeline products include SEL-212, SEL-403, SEL-302 and SEL-302. It utilizes synthetic vaccine particle (S …
  • Mentor Graphics Corporation:企業の戦略・SWOT・財務分析
    Mentor Graphics Corporation - Strategy, SWOT and Corporate Finance Report Summary Mentor Graphics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Essential Energy Services Ltd (ESN):石油・ガス:M&Aディール及び事業提携情報
    Summary Essential Energy Services Ltd (Essential Energy) is an oil and gas company that offers oilfield services. The company provides coil well services and tool services. Its services include coil tubing, fluid and nitrogen pumping, completion, abandonment, and downhole tools and equipment rental …
  • Falck Renewables S.p.A. (FKR):企業の財務・戦略的SWOT分析
    Falck Renewables S.p.A. (FKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Immusoft Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Immusoft Corp (Immusoft) is a biotechnology start-up company that focuses on the development of autologous cell therapy platform for the treatment of genetic diseases. The company’s technology includes immune system programming (ISP) technology, gene delivery technology and lymphopoiesis cul …
  • Polski Koncern Naftowy Orlen SA (PKN):石油・ガス:M&Aディール及び事業提携情報
    Summary Polski Koncern Naftowy Orlen SA (PKN Orlen) is an integrated oil and gas company. It explores for and produces crude oil and natural gas; manufactures petroleum products; transports and sells crude oil and petroleum products; and markets natural gas and natural gas liquids. Its product portf …
  • TEGNA Inc (TGNA):企業の財務・戦略的SWOT分析
    TEGNA Inc (TGNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Chennai Meenakshi Multispeciality Hospital Ltd (523489):企業の財務・戦略的SWOT分析
    Chennai Meenakshi Multispeciality Hospital Ltd (523489) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’ …
  • DNAtrix Inc:医療機器:M&Aディール及び事業提携情報
    Summary DNAtrix Inc (DNAtrix) is an independent clinical stage, biotechnology company that focuses on the development of oncolytic immunotherapies for cancer. The company’s portfolio of pipeline products includes DNX-2401, a modified common cold virus that targets and kills cancer cells selectively; …
  • Cryogenmash:企業の戦略的SWOT分析
    Cryogenmash - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • IndiPharm Inc-製薬・医療分野:企業M&A・提携分析
    Summary IndiPharm Inc (IndiPharm) is a clinical research organization that provides drug safety services to support clinical research and marketed products. The organization offers CRO services such as preparing and filing regulatory submissions, obtaining required import and export licenses, protoc …
  • Lakeview Hotel Investment Corp.:企業の戦略・SWOT・財務情報
    Lakeview Hotel Investment Corp. - Strategy, SWOT and Corporate Finance Report Summary Lakeview Hotel Investment Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆